Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3016882rdf:typepubmed:Citationlld:pubmed
pubmed-article:3016882lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:3016882lifeskim:mentionsumls-concept:C0019900lld:lifeskim
pubmed-article:3016882lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3016882lifeskim:mentionsumls-concept:C0398650lld:lifeskim
pubmed-article:3016882pubmed:issue5lld:pubmed
pubmed-article:3016882pubmed:dateCreated1986-9-17lld:pubmed
pubmed-article:3016882pubmed:abstractTextOver the past 3 yr we have treated 6 homosexual men (age 22-55 yr) with immune thrombocytopenic purpura. 4 of the 6 have antibody to HTLV-III in their serum, 1 of these patients has the acquired immune deficiency syndrome (AIDS), 1 has AIDS-related-complex (ARC), and a 3rd has persistent generalised lymphadenopathy (PGL). The platelet count at presentation was between 2 and 35 X 10(9)/l and in each case a bone marrow confirmed active platelet production. Antiplatelet antibodies were demonstrated in 3 of 4 patients tested. 3 of the 6 patients showed a partial response to prednisolone, 2 showed little or no response and the 6th showed a good response. 2 patients received high dose i.v. immunoglobulin - 1 had an excellent response prior to splenectomy, the other showed no response. 5 of the 6 patients had a splenectomy. 3 had a lasting remission (12-27 months after splenectomy), 1 of these has HTLV-III antibodies; 1 had a remission lasting 1 yr, followed by fluctuating thrombocytopenia (21-130 X 10(9)/l) and 1 showed no response.lld:pubmed
pubmed-article:3016882pubmed:languageenglld:pubmed
pubmed-article:3016882pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3016882pubmed:citationSubsetIMlld:pubmed
pubmed-article:3016882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3016882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3016882pubmed:statusMEDLINElld:pubmed
pubmed-article:3016882pubmed:monthMaylld:pubmed
pubmed-article:3016882pubmed:issn0036-553Xlld:pubmed
pubmed-article:3016882pubmed:authorpubmed-author:LaoBBlld:pubmed
pubmed-article:3016882pubmed:authorpubmed-author:CostelloCClld:pubmed
pubmed-article:3016882pubmed:authorpubmed-author:TreacyMMlld:pubmed
pubmed-article:3016882pubmed:issnTypePrintlld:pubmed
pubmed-article:3016882pubmed:volume36lld:pubmed
pubmed-article:3016882pubmed:ownerNLMlld:pubmed
pubmed-article:3016882pubmed:authorsCompleteYlld:pubmed
pubmed-article:3016882pubmed:pagination507-10lld:pubmed
pubmed-article:3016882pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:meshHeadingpubmed-meshheading:3016882-...lld:pubmed
pubmed-article:3016882pubmed:year1986lld:pubmed
pubmed-article:3016882pubmed:articleTitleTreatment of immune thrombocytopenic purpura in homosexual men.lld:pubmed
pubmed-article:3016882pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3016882pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3016882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3016882lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3016882lld:pubmed